|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 90.78 USD | +9.10% |
|
+26.51% | +10.87% |
| 09-04 | Tarsus Pharmaceuticals Shares Rise After Closing Alkeus Pharmaceuticals Acquisition | MT |
| 09-04 | Tarsus Pharmaceuticals Closes Acquisition of Alkeus Pharmaceuticals | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.65B | - | - | - | ||
| 84.22B | |||||
| 60.48B | |||||
| 59.43B | - | ||||
| 50.31B | |||||
| 48.91B |
Select your edition
All financial news and data tailored to specific country editions
